Innovative Manufacturing Focus Surmasis specializes in transdermal patch manufacturing with advanced capabilities in hydrogel reservoir and matrix patches, presenting a promising partnership opportunity for pharmaceutical companies seeking specialized drug delivery solutions.

Growth Potential Although currently generating between one to ten million dollars in revenue, Surmasis's strategic focus on process and product development positions it for expansion, making it an attractive target for clients looking to scale up or innovate their transdermal portfolio.

Process & Tech Transfer The company's expertise in tech transfer and scale-up services offers opportunities for pharmaceutical firms aiming to commercialize new formulations efficiently, especially those transitioning early-stage products into large-scale manufacturing.

Partnership-Driven Model Surmasis's role as a contract manufacturer and its involvement in FDA clinical batches suggest active engagement in collaborative projects, ideal for companies seeking reliable manufacturing partners for regulatory-approved product manufacturing.

Technology Stack & Innovation With a modern technology stack that includes analytics, monitoring, and web development tools, Surmasis demonstrates a focus on operational efficiency and quality assurance, appealing to clients prioritizing technological sophistication in manufacturing.